down arrow

Natural Capsules

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE936B01015
  • NSEID: NATCAPSUQ
  • BSEID: 524654
INR
212.10
0.55 (0.26%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 3.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Natural Capsules Ltd stock-summary
stock-summary
Natural Capsules Ltd
Micro Cap
Pharmaceuticals & Drugs
Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore. The Company is one of the leading manufacturers of hard capsule shells in India. The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. NCL expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
Company Coordinates stock-summary
Company Details
Trident Towers 4th Floor No 23, 100Feet Road Jayanagar IIBlock Bangalore Karnataka : 560011
stock-summary
Tel: 91-080-26671571/26671573/26671581
stock-summary
company.sec@naturalcapsules.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 9.34 Cr
Number of Shares
93.36 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Jun-2024
93.36
9.34
14159
10
Rights Partly Paid to Fully Paid Up
17-Oct-2023
93.22
9.32
46403
10
Rights Partly Paid to Fully Paid Up
28-Jun-2023
92.75
9.28
43056
10
Rights Partly Paid to Fully Paid Up
17-Apr-2023
92.32
9.23
15548
10
Rights Partly Paid to Fully Paid Up
03-Mar-2023
92.17
9.22
56002
10
Rights Partly Paid to Fully Paid Up
12-Jan-2023
91.61
9.16
2927866
10
Rights Partly Paid to Fully Paid Up
11-Jan-2023
1.23
12.28
2927866
10
Rights Partly Paid to Fully Paid Up
10-Nov-2022
93.49
9.35
3116350
10
Right Issues
11-Nov-2021
93.49
9.35
3116350
10
Right Issues
11-Nov-2021
93.49
9.35
3116350
10
Right Issues
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Tajos Investments Private Limited (12.12%)

Highest Public shareholder

Tarinika Management Llp (3.22%)

Individual Investors Holdings

32.86%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Laxminarayan Moondra
Whole-time Director
35.96 lacs
Satyanarayan Mundra
Whole-time Director
38.2 lacs
C P Rangachar
Chairman & Independent Directo
6.9 lacs
Sunil L Mundra
Managing Director
75.58 lacs
Sushil Kumar Mundra
Director
6.0 lacs
Jyothi Mundra
Director
6.0 lacs
Pramod Kasat
Independent Director
6.9 lacs
Shilpa Burman
Company Sec. & Compli. Officer
0
Shirish Gundopant Belapure
Independent Director
6.45 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Capsules
57.45
96.10%
Other Operating Income
2.33
3.90%
 
96.1
Capsules
3.9
Capsules
3.9
Other Operating Income
96.1
Other Operating Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
44 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 221 Cr (Micro Cap)

stock-summary
P/E

204.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.37

stock-summary
Return on Equity

0.93%

stock-summary
Price to Book

0.94